This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n10http://linked.opendata.cz/resource/drugbank/drug/DB07622/identifier/pdb/
n11http://linked.opendata.cz/resource/drugbank/drug/DB07622/identifier/pubchem-compound/
n14http://bio2rdf.org/drugbank:
n9http://linked.opendata.cz/resource/drugbank/drug/DB07622/identifier/pubchem-substance/
n13http://linked.opendata.cz/resource/drugbank/drug/DB07622/identifier/drugbank/
admshttp://www.w3.org/ns/adms#
n7http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
n12http://linked.opendata.cz/resource/drugbank/drug/DB07622/identifier/chemspider/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB07622
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n7:DB07622 n14:DB07622
dcterms:title
1-(3-(2,4-DIMETHYLTHIAZOL-5-YL)-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)-3-(4-METHYLPIPERAZIN-1-YL)UREA
adms:identifier
n9:99444093 n10:D42 n11:5288018 n12:4450263 n13:DB07622
n3:IUPAC-Name
n4:271B5644-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B564A-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5649-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5646-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5647-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5648-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B5642-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B5640-363D-11E5-9242-09173F13E4C5 n4:271B5643-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B5641-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5650-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5651-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B564B-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B564C-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B564E-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B564D-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B564F-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B5656-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5658-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5659-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5655-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5654-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5657-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5645-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B5652-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5653-363D-11E5-9242-09173F13E4C5